6 results on '"SGLT1 Expression"'
Search Results
2. Empagliflozin Ammeliorates High Glucose Induced-Cardiac Dysfuntion in Human iPSC-Derived Cardiomyocytes
- Author
-
Kwong-Man Ng, Yee-Man Lau, Vidhu Dhandhania, Zhu-Jun Cai, Yee-Ki Lee, Wing-Hon Lai, Hung-Fat Tse, and Chung-Wah Siu
- Subjects
hiPSC-derived Cardiomyocytes ,Sodium Glucose Co-transporter (SGLT) ,HG Treatment ,SGLT1 Expression ,Diabetic Cardiomyopathy ,Medicine ,Science - Abstract
Abstract Empagliflozin, a sodium-glucose co-transporter (SGLT) inhibitor, reduces heart failure and sudden cardiac death but the underlying mechanisms remain elusive. In cardiomyocytes, SGLT1 and SGLT2 expression is upregulated in diabetes mellitus, heart failure, and myocardial infarction. We hypothesise that empagliflozin exerts direct effects on cardiomyocytes that attenuate diabetic cardiomyopathy. To test this hypothesis, cardiomyocytes derived from human induced pluripotent stem cells (hiPSCs) were used to test the potential effects of empagliflozin on neutralization of cardiac dysfunction induced by diabetic-like cultures. Our results indicated that insulin-free high glucose culture significantly increased the size of and NPPB, SGLT1 and SGLT2 expression of hiPSC-derived cardiomyocytes. In addition, high glucose-treated hiPSC-derived cardiomyocytes exhibited reduced contractility regardless of the increased calcium transient capacity. Interestingly, application of empagliflozin before or after high glucose treatment effectively reduced the high glucose-induced cardiac abnormalities. Since application of empagliflozin did not significantly alter viability or glycolytic capacity of the hiPSC-derived cardiomyocytes, it is plausible that empagliflozin exerts its effects via the down-regulation of SGLT1, SGLT2 and GLUT1 expression. These observations provide supportive evidence that may help explain its unexpected benefit observed in the EMPA-REG trial.
- Published
- 2018
- Full Text
- View/download PDF
3. Rice (Oryza sativa japonica) albumin hydrolysates suppress postprandial blood glucose elevation by adsorbing glucose and inhibiting Na+-d-glucose cotransporter SGLT1 expression
- Author
-
Hitoshi Kumagai, Shigenobu Ina, Hanae Nakamura, Yusuke Yamaguchi, Aya Hamada, and Hitomi Kumagai
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Rice protein ,animal structures ,endocrine system diseases ,Rice albumin peptides ,Medicine (miscellaneous) ,Hydrolysate ,03 medical and health sciences ,chemistry.chemical_compound ,0404 agricultural biotechnology ,D-Glucose ,Internal medicine ,Diabetes mellitus ,medicine ,Blood glucose ,TX341-641 ,030109 nutrition & dietetics ,Nutrition and Dietetics ,Nutrition. Foods and food supply ,Albumin ,Glucose adsorption ,SGLT1 expression ,04 agricultural and veterinary sciences ,Oral glucose tolerance tests ,Trypsin ,medicine.disease ,040401 food science ,In vitro ,Endocrinology ,Postprandial ,chemistry ,Cotransporter ,Food Science ,medicine.drug - Abstract
The mechanism of the suppressive effect of rice albumin (RA) on postprandial hyperglycemia after glucose loading was investigated. In order to examine if small peptides derived from RA are responsible for prevention of postprandial hyperglycemia, RA was hydrolysed to indigestible high-molecular-weight peptides (HMP) and low-molecular-weight peptides (LMP) by trypsin, HMP and LMP being fractionated by gel-filtration chromatography. In oral glucose tolerance test (OGTT), both HMP and LMP suppressed the increase in blood glucose levels. In vitro diffusion test results showed that HMP adsorbed glucose and retarded its diffusion rate like dietary fibers. On the other hand, LMP suppressed the expression of sodium-dependent glucose transporter-1 (SGLT1) in STC-1 cells. Therefore, the suppressive effect of RA on postprandial hyperglycemia would be due to the dual actions of HMP and LMP. Our results demonstrated the potential use of RA as a functional food material to prevent diabetes.
- Published
- 2020
- Full Text
- View/download PDF
4. Empagliflozin Ammeliorates High Glucose Induced-Cardiac Dysfuntion in Human iPSC-Derived Cardiomyocytes
- Author
-
Vidhu Dhandhania, Yee-Man Lau, Zhu-Jun Cai, Yee-Ki Lee, Wing-Hon Lai, Chung-Wah Siu, Hung-Fat Tse, and Kwong-Man Ng
- Subjects
0301 basic medicine ,Male ,Diabetic Cardiomyopathies ,Science ,Induced Pluripotent Stem Cells ,030204 cardiovascular system & hematology ,Pharmacology ,Article ,Sudden cardiac death ,Cell Line ,Contractility ,HG Treatment ,03 medical and health sciences ,0302 clinical medicine ,Glucosides ,Diabetic cardiomyopathy ,Sodium Glucose Co-transporter (SGLT) ,medicine ,Empagliflozin ,Myocyte ,Humans ,SGLT1 Expression ,Myocytes, Cardiac ,Myocardial infarction ,Benzhydryl Compounds ,Sodium-Glucose Transporter 2 Inhibitors ,Cells, Cultured ,Cell Size ,Multidisciplinary ,biology ,Diabetic Cardiomyopathy ,business.industry ,medicine.disease ,hiPSC-derived Cardiomyocytes ,030104 developmental biology ,Glucose ,Heart failure ,biology.protein ,Medicine ,GLUT1 ,business - Abstract
Empagliflozin, a sodium-glucose co-transporter (SGLT) inhibitor, reduces heart failure and sudden cardiac death but the underlying mechanisms remain elusive. In cardiomyocytes, SGLT1 and SGLT2 expression is upregulated in diabetes mellitus, heart failure, and myocardial infarction. We hypothesise that empagliflozin exerts direct effects on cardiomyocytes that attenuate diabetic cardiomyopathy. To test this hypothesis, cardiomyocytes derived from human induced pluripotent stem cells (hiPSCs) were used to test the potential effects of empagliflozin on neutralization of cardiac dysfunction induced by diabetic-like cultures. Our results indicated that insulin-free high glucose culture significantly increased the size of and NPPB, SGLT1 and SGLT2 expression of hiPSC-derived cardiomyocytes. In addition, high glucose-treated hiPSC-derived cardiomyocytes exhibited reduced contractility regardless of the increased calcium transient capacity. Interestingly, application of empagliflozin before or after high glucose treatment effectively reduced the high glucose-induced cardiac abnormalities. Since application of empagliflozin did not significantly alter viability or glycolytic capacity of the hiPSC-derived cardiomyocytes, it is plausible that empagliflozin exerts its effects via the down-regulation of SGLT1, SGLT2 and GLUT1 expression. These observations provide supportive evidence that may help explain its unexpected benefit observed in the EMPA-REG trial.
- Published
- 2018
5. Rice (Oryza sativa japonica) albumin hydrolysates suppress postprandial blood glucose elevation by adsorbing glucose and inhibiting Na+-d-glucose cotransporter SGLT1 expression.
- Author
-
Ina, Shigenobu, Hamada, Aya, Nakamura, Hanae, Yamaguchi, Yusuke, Kumagai, Hitoshi, and Kumagai, Hitomi
- Abstract
• Rice albumin was digested to indigestible HMP (14 kDa) and LMP (<2 kDa) by trypsin. • HMP and LMP suppressed the blood glucose and insulin elevation in rats (OGTT). • HMP adsorbed glucose and retarded its diffusion rate like dietary fibers. • LMP suppressed the expression of sodium-dependent glucose transporter-1 (SGLT1). The mechanism of the suppressive effect of rice albumin (RA) on postprandial hyperglycemia after glucose loading was investigated. In order to examine if small peptides derived from RA are responsible for prevention of postprandial hyperglycemia, RA was hydrolysed to indigestible high-molecular-weight peptides (HMP) and low-molecular-weight peptides (LMP) by trypsin, HMP and LMP being fractionated by gel-filtration chromatography. In oral glucose tolerance test (OGTT), both HMP and LMP suppressed the increase in blood glucose levels. In vitro diffusion test results showed that HMP adsorbed glucose and retarded its diffusion rate like dietary fibers. On the other hand, LMP suppressed the expression of sodium-dependent glucose transporter-1 (SGLT1) in STC-1 cells. Therefore, the suppressive effect of RA on postprandial hyperglycemia would be due to the dual actions of HMP and LMP. Our results demonstrated the potential use of RA as a functional food material to prevent diabetes. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
6. Rosmarinic acid, major phenolic constituent of Greek sage herbal tea, modulates rat intestinal SGLT1 levels with effects on blood glucose
- Author
-
Jonathan M. Wilson, Marisa Azevedo, Cristina Pereira-Wilson, Cristovao F. Lima, Manuel Fernandes-Ferreira, Maria Judite Almeida, and Universidade do Minho
- Subjects
Intestinal glucose absorption ,Blood Glucose ,Male ,Soybean meal ,Depsides ,Salvia fruticosa Miller ,Diabetes Mellitus, Experimental ,03 medical and health sciences ,chemistry.chemical_compound ,Herbal tea ,Diabetes mellitus ,Sodium-Glucose Transporter 1 ,0302 clinical medicine ,Glucagon-Like Peptide 1 ,Animals ,Hypoglycemic Agents ,Medicine ,Intestinal Mucosa ,Rats, Wistar ,Salvia officinalis ,030304 developmental biology ,Glucose Transporter Type 2 ,2. Zero hunger ,0303 health sciences ,Science & Technology ,Microvilli ,Traditional medicine ,business.industry ,SAGE ,Rosmarinic acid ,digestive, oral, and skin physiology ,SGLT1 expression ,Rats ,3. Good health ,Enterocytes ,Jejunum ,chemistry ,Cinnamates ,030220 oncology & carcinogenesis ,Plant Preparations ,business ,Food Science ,Biotechnology - Abstract
Scope: Previous results suggested that the effects of Salvia fruticosa tea (SFT) drinking on glucose regulation might be at the intestinal level. Here we aim to characterize the effects of SFT treatment and of its main phenolic constituent – rosmarinic acid (RA) – on the levels and localization of the intestinal Na+/glucose cotransporter-1 (SGLT1), the facilitative glucose transporter 2 and glucagon-like peptide-1 (GLP-1). Methods and results: Two models of SGLT1 induction in rats were used: through diabetes induction with streptozotocin (STZ) and through dietary carbohydrate manipulation. Drinking water was replaced with SFT or RA and blood parameters, liver glycogen and the levels of different proteins in enterocytes quantified. Two weeks of SFT treatment stabilized fasting blood glucose levels in STZ-diabetic animals. The increase in SGLT1 localized to the enterocyte brush-border membrane (BBM) induced by STZ treatment was significantly abrogated by treatment with SFT, without significant changes in total cellular transporter protein levels. No effects were observed on glucose transporter 2, Na+/K+-ATPase or glucagon-like peptide-1 levels by SFT. Additionally, SFT and RA for 4 days significantly inhibited the carbohydrate-induced adaptive increase of SGLT1 in BBM. Conclusion: SFT and RA modulate the trafficking of SGLT1 to the BBM and may contribute to the control of plasma glucose., We thank NANTA, Fábrica de Moagem do Marco S.A., Portugal, for offering the Soybean meal 47.5 (LC diet). M. F. A. was supported by the Foundation for Science and Technology, Portugal, through the grant SFRH/BD/12527/2003. This work was supported by the Foundation for Science and Technology, Portugal, through the research grant POCI/AGR/62040/2004.
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.